Consistently, cell assays in vitro showed that cancer cells with driver genetic alterations accompanied by ATM deficiency had high capability in proliferation and invasion, thus suggesting that ATM may assist driver oncogenes in enhancing tumor-promoting effects. The gene discussed is ATM; the disease is neoplasm.